Structural basis of membrane engagement and polyreactivity control in HIV-1 MPER broadly neutralizing antibodies
Cho, S.Y., Wilson, I.A.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
wwPDB Validation 3D Report Full Report
Macromolecule Content 
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Antibody VRC42.01 Fab heavy chain | 228 | Homo sapiens | Mutation(s): 0  | ![]() | |
Entity ID: 2 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Antibody VRC42.01 Fab light chain | 213 | Homo sapiens | Mutation(s): 0  | ![]() | |
Entity ID: 3 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Transmembrane protein gp41 | 19 | Human immunodeficiency virus 1 | Mutation(s): 0  | ![]() | |
UniProt | |||||
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | Q73372 | ||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
| Length ( Å ) | Angle ( ˚ ) |
|---|---|
| a = 199.443 | α = 90 |
| b = 73.524 | β = 99.43 |
| c = 44.214 | γ = 90 |
| Software Name | Purpose |
|---|---|
| PHENIX | refinement |
| HKL-2000 | data reduction |
| HKL-2000 | data scaling |
| PHASER | phasing |
| Funding Organization | Location | Grant Number |
|---|---|---|
| National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) | United States | AI144462 |
| Bill & Melinda Gates Foundation | United States | INV-007522 |
| Bill & Melinda Gates Foundation | United States | INV-008813 |